API’s and Dietary Ingredients

Linnea® Ginkgo Biloba
Botanical extract

Products

GINKGO BILOBA EPG 246
Refined and quantified dry extract
Between 22.0% and 27.0% ginkgo flavon glycosides
Between 2.6% to 3.2% bilobalide
Between 2.8% to 3.4% ginkgolides A, B and C

GINKGO BILOBA ETHANOL
Herbal extract
NLT 24% ginkgo flavon glycosides
NLT 6.0% terpene lactones

Pharma use

Anti-dementia
Circulation

Dietary use

Memory loss and concentration disorders
Minor circulatory disorders

Info

Cas number
90045-36-6

Certifications
Site GMP Certified
Linnea® Cannabinoids

Phytocannabinoids for pharmaceutical purposes

Every day, we develop and produce the finest cannabis and CBD extracts complying with the highest industry standards.

There is a large number of ongoing clinical and preclinical studies focusing on cannabinoids. Cannabis and its derivates have a multi-level role in the organism, indicating the potential extent of a complex therapeutic scenario and representing an exciting target for disease management and health promotion.